The Enterprise Value as of September 2024 (TTM) for Rocket Pharmaceuticals, Inc. (RCKT) is 1.73B

According to Rocket Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.73B. This represents a change of -20.04% compared to the average of 2.17B of the last 4 quarters.

Rocket Pharmaceuticals, Inc. (RCKT) Historical Enterprise Value (quarterly & annually)

How has RCKT Enterprise Value performed in the past?

The mean historical Enterprise Value of Rocket Pharmaceuticals, Inc. over the last ten years is 960.28M. The current 1.73B Enterprise Value has changed 17.96% with respect to the historical average. Over the past ten years (40 quarters), RCKT's Enterprise Value was at its highest in in the December 2020 quarter at 2.79B. The Enterprise Value was at its lowest in in the March 2015 quarter at -2859559.76.

Rocket Pharmaceuticals, Inc. (RCKT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Rocket Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rocket Pharmaceuticals, Inc. (RCKT) Average Enterprise Value

How has RCKT Enterprise Value performed in the past?

The current Enterprise Value of Rocket Pharmaceuticals, Inc. (RCKT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Rocket Pharmaceuticals, Inc. (RCKT) Enterprise Value vs. Peers

How is RCKT’s Enterprise Value compared to its peers?

Rocket Pharmaceuticals, Inc.’s Enterprise Value is greater than uniQure N.V. (510.02M), less than Rhythm Pharmaceuticals, Inc. (3.12B), greater than Solid Biosciences Inc. (220.06M), greater than MeiraGTx Holdings plc (312.67M), less than Vaxcyte, Inc. (13.42B), greater than Larimar Therapeutics, Inc. (400.15M), greater than Syndax Pharmaceuticals, Inc. (1.44B), less than Merus N.V. (2.81B), greater than Sutro Biopharma, Inc. (402.91M), greater than Stoke Therapeutics, Inc. (587.25M), greater than Pliant Therapeutics, Inc. (701.55M), less than Dyne Therapeutics, Inc. (2.87B), less than Cytokinetics, Incorporated (7.28B), less than Revolution Medicines, Inc. (7.25B), greater than REGENXBIO Inc. (730.60M), greater than Day One Biopharmaceuticals, Inc. (956.75M), greater than Replimune Group, Inc. (638.93M), less than Mirum Pharmaceuticals, Inc. (2.01B), greater than Viridian Therapeutics, Inc. (1.29B), greater than Inozyme Pharma, Inc. (407.26M),

Build a custom stock screener for Rocket Pharmaceuticals, Inc. (RCKT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rocket Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rocket Pharmaceuticals, Inc. (RCKT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rocket Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.